Portland, OR, July 01, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Liquid Biopsy Market garnered $1.20 billion in 2020, and is estimated to reach $6.80 billion by 2028, witnessing a CAGR of 20.9% from 2021 to 2028. The report offers an extensive analysis of changing market trends, top segments, major investment pockets, regional scenarios, value chain, and competitive landscape.
Download Sample Report at: https://www.alliedmarketresearch.com/request-sample/1891
Increase in incidences and prevalence of various cancer types, rise in demand for safe and non-invasive procedures, and advantages of liquid biopsy launches and technology drive the growth of the global liquid biopsy market. However, lack of awareness in developing and underdeveloped regions hinder the market growth. On the other hand, use of liquid biopsy for treatment of rare cancer and untapped potential of emerging markets present new opportunities in the coming years.
Covid-19 Scenario:
- The market has suspended early diagnosis programs owing to the lockdown imposed by government bodies. In addition, there has been a decrease in screenings, visits, therapies, and surgeries related to cancer.
- The pandemic has also affected the logistics and supplies of cancer diagnostic raw materials and components and other essential commodities required for the production of liquid biopsy.
The report offers detailed segmentation of the global liquid biopsy market based on product type, container type, formulation, application, distribution channel, and region.
Based on cancer type, the lung cancer segment held the highest market share, accounting for nearly one-third of the total share in 2020, and is projected to maintain its lead position during the forecast period. However, the breast cancer segment is estimated to register the highest CAGR of 26.0% from 2021 to 2028.
Enquiry for Short-term and Long-term Impacts of COVID-19 at: https://www.alliedmarketresearch.com/purchase-enquiry/1891
Based on end user, the hospitals and laboratories segment accounted for the largest market share in 2020, contributing to 94% of the global Liquid biopsy market, and is estimated to continue its leadership status during the forecast period. However, the government and academic research center segment is projected to witness the largest CAGR of 21.9% from 2021 to 2028.
Based on region, North America contributed to the largest market share in 2019, holding more than two-fifths of the total share, and is expected to maintain its dominant share in terms of revenue by 2028. However, Asia-Pacific is estimated to portray the highest CAGR of 22.7% during the forecast period. Other provinces covered in the report include LAMEA and Europe.
Leading players of the global liquid biopsy market analyzed in the research include Johnson & Johnson, Laboratory Corporation of America Holdings, MDxHealth SA, QIAGEN N.V., Bio-Rad Laboratories, Inc, Biocept Inc., Guardant Health Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd. (FOUNDATION MEDICINE, INC.),and Thermo Fisher Scientific Inc.
Avenue Basic Plan | Library Access | 1 Year Subscription |
Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.
Avenue Library Subscription | Request for 14 days free trial of before buying: https://www.alliedmarketresearch.com/avenue/trial/starter
Get more information: https://www.alliedmarketresearch.com/library-access
We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.
Similar Reports:
Biopsy Devices Market - Global Opportunity Analysis and Industry Forecast, 2020–2028
Breast Biopsy Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Prostate Biopsy Market - Global Opportunity Analysis and Industry Forecast, 2019-2028
Biliary Biopsy Forceps Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
Lung Biopsy Devices Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
Breast Cancer Liquid Biopsy Market - Global Opportunity Analysis and Industry Forecast, 2019–2028
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.